Skip to main content
. 2016 Oct 20;139(12):3163–3169. doi: 10.1093/brain/aww242

Table 1.

Association results for the three associated loci

Discovery stage Replication stage Combined stages Heterogeneity
SNP CHR BP Minor allele (a) Major allele (A) P OR (95% CI) P OR (95% CI) P OR (95% CI) I2 Tau2
rs10937625 4 5 128 159 C T 4.42 × 10−6 0.80 (0.73–0.88) 7.36 × 10−4 0.77 (0.66–0.90) 5.21 × 10−10 0.80 (0.74–0.87) 39.6% 0.0049
rs17590046 4 24 362 541 C T 3.39 × 10−6 0.80 (0.73–0.88) 6.81 × 10−4 0.75 (0.64–0.89) 1.39 × 10−9 0.79 (0.72–0.86) 47.6% 0.0082
rs12764057 10 68 845 715 G T 3.99 × 10−5 1.28 (1.19–1.39) 0.275 1.07 (0.94–1.22) 1.19 × 10−8 1.17 (1.09–1.26) 61.6% 0.0089
rs10822974 10 68 850 419 G A 3.02 × 10−5 1.27 (1.18–1.37) 0.796 0.98 (0.86–1.13) 1.65 × 10−7 1.16 (1.08–1.24) 67.3% 0.0118
rs7903491 10 68 917 164 A G 1.10 × 10−6 1.20 (1.11–1.30) 0.407 1.05 (0.93–1.20) 2.49 × 10−7 1.10 (1.03–1.18) 92.4% 0.0676

SNP = dbSNP ID of the marker; CHR = chromosome; BP = chromosomal position (GRCh37), OR (95% CI) = odds ratio with 95% confidence interval; I2 = ratio of true heterogeneity to total observed variation; tau2 = between studies variance. Heterogeneity metrics were calculated between samples included in: discovery stage with European descent, discovery stage with North American descent, replication stage with European descent and replication stage with North American descent.